MDT

88.44

-1.53%↓

VEEV

227.74

-1.64%↓

A

113.65

-2.76%↓

HQY

87.08

-1.46%↓

PDCO

31.26

0%↓

MDT

88.44

-1.53%↓

VEEV

227.74

-1.64%↓

A

113.65

-2.76%↓

HQY

87.08

-1.46%↓

PDCO

31.26

0%↓

MDT

88.44

-1.53%↓

VEEV

227.74

-1.64%↓

A

113.65

-2.76%↓

HQY

87.08

-1.46%↓

PDCO

31.26

0%↓

MDT

88.44

-1.53%↓

VEEV

227.74

-1.64%↓

A

113.65

-2.76%↓

HQY

87.08

-1.46%↓

PDCO

31.26

0%↓

MDT

88.44

-1.53%↓

VEEV

227.74

-1.64%↓

A

113.65

-2.76%↓

HQY

87.08

-1.46%↓

PDCO

31.26

0%↓

Search

STERIS PLC

Suletud

SektorTervishoid

225.43 -0.57

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

221.31

Max

227.5

Põhinäitajad

By Trading Economics

Sissetulek

16M

173M

Müük

42M

1.4B

P/E

Sektori keskmine

36.498

63.778

Aktsiakasum

2.32

Dividenditootlus

1.01

Kasumimarginaal

12.643

Töötajad

18,000

EBITDA

-85M

245M

Soovitused

By TipRanks

Soovitused

Osta

12 kuu keskmine prognoos

+17.4% upside

Dividendid

By Dow Jones

Dividenditootlus

Sektori keskmine

1.01%

2.39%

Järgmine tulemuste avaldamine

7. mai 2025

Järgmine dividendimakse kuupäev

25. juuni 2025

Järgmine aktsia dividendi kuupäev (ex-date)

11. juuni 2025

Turustatistika

By TradingEconomics

Turukapital

22B

Eelmine avamishind

226

Eelmine sulgemishind

225.43

Uudiste sentiment

By Acuity

40%

60%

138 / 386 Pingereas Healthcare

Tehniline skoor

By Trading Central

Kindlus

Bearish Evidence

STERIS PLC Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

5. veebr 2025, 21:35 UTC

Tulu

Steris: Outlook Does Not Reflect Any Potential Impact From New Tariffs >STE

5. veebr 2025, 21:34 UTC

Tulu

Steris: FY25 Guidance Change Is Primarily Due to Currency >STE

5. veebr 2025, 21:34 UTC

Tulu

Steris Cuts FY25 Revenue View to Increase of About 6% From Prior View for 6.5%-7%>STE

5. veebr 2025, 21:33 UTC

Tulu

Steris 3Q EPS $1.75 >STE

5. veebr 2025, 21:30 UTC

Tulu

Steris Sees FY Adj EPS $9.05-Adj EPS $9.15 >STE

5. veebr 2025, 21:30 UTC

Tulu

Steris 3Q Rev $1.4B >STE

5. veebr 2025, 21:30 UTC

Tulu

Steris 3Q Adj EPS $2.32 >STE

6. nov 2024, 21:41 UTC

Tulu

Steris Backs FY25 Revenue Up 6.5%-7.5% >STE

6. nov 2024, 21:40 UTC

Tulu

Steris 2Q EPS $1.51 >STE

6. nov 2024, 21:30 UTC

Tulu

Steris Sees FY Adj EPS $9.05-Adj EPS $9.25 >STE

6. nov 2024, 21:30 UTC

Tulu

Steris 2Q Adj EPS $2.14 >STE

6. nov 2024, 21:30 UTC

Tulu

Steris 2Q Rev $1.3B >STE

6. aug 2024, 20:36 UTC

Tulu

Steris 1Q Adj EPS $2.03 >STE

6. aug 2024, 20:30 UTC

Tulu

Steris 1Q Net $139.9M >STE

6. aug 2024, 20:30 UTC

Tulu

Steris 1Q EPS $1.41 >STE

6. aug 2024, 20:30 UTC

Tulu

Steris Sees FY Adj EPS $9.05-Adj EPS $9.25 >STE

3. juuni 2024, 11:03 UTC

Omandamised, ülevõtmised, äriostud

PEAK ROCK Cap Affil COMPLETES PREVIOUSLY ANNOUNCED ACQUISITION of HUFRIEDYGROUP

31. mai 2024, 20:47 UTC

Omandamised, ülevõtmised, äriostud

Steris Completes $787.5M Sale of Dental Segment to Peak Rock Capital

8. mai 2024, 20:40 UTC

Tulu

Steris Sees FY25 Adj EPS $9.05-Adj EPS $9.25 >STE

8. mai 2024, 20:39 UTC

Tulu

Steris: Plan Includes Restructuring of the Healthcare Surgical Business in Europe >STE

8. mai 2024, 20:39 UTC

Tulu

Steris Announcing a Targeted Restructuring Plan >STE

8. mai 2024, 20:39 UTC

Tulu

Steris 4Q EPS $3.81 >STE

8. mai 2024, 20:30 UTC

Tulu

Steris 4Q Adj EPS $2.58 >STE

11. apr 2024, 11:01 UTC

Omandamised, ülevõtmised, äriostud

Steris Expects Resulting Benefit of Reduction in Interest Expense to Be About $0.35 Per Shr >STE

11. apr 2024, 11:00 UTC

Omandamised, ülevõtmised, äriostud

Steris: Transaction Is Anticipated to Close in 1Q of Fiscal Yr 2025 >STE

11. apr 2024, 10:59 UTC

Omandamised, ülevõtmised, äriostud

Steris: Transaction Terms Include Opportunity to Receive Additional Earnout of Up to $12.5M >STE

11. apr 2024, 10:59 UTC

Omandamised, ülevõtmised, äriostud

Steris: Transaction Is Structured as Equity Sale >STE

11. apr 2024, 10:58 UTC

Omandamised, ülevõtmised, äriostud

Steris Enters Agreement to Divest Dental Segment to Peak Rock Cap for $787.5M >STE

11. apr 2024, 10:58 UTC

Omandamised, ülevõtmised, äriostud

STERIS to Sell Dental Segment to an Affiliate of Peak Rock Capital for $787.5M

Võrdlus sarnastega

Hinnamuutus

STERIS PLC Prognoos

Hinnasiht

By TipRanks

17.4% tõus

12 kuu keskmine prognoos

Keskmine 265 USD  17.4%

Kõrge 265 USD

Madal 265 USD

Põhineb 3 Wall Streeti analüütiku instrumendi STERIS PLC 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Osta

3 ratings

2

Osta

1

Hoia

0

Müü

Tehniline skoor

By Trading Central

224.21 / 226.14Toetus ja vastupanu

Lühikene perspektiiv

Bearish Evidence

Keskpikk perspektiiv

Strong Bullish Evidence

Pikk perspektiiv

Weak Bullish Evidence

Sentiment

By Acuity

138 / 386 Pingereas Tervishoid

Uudiste sentiment

Languse märgid

Volatiilsus

Alla keskmise

Uudismaht (RCV)

Üle keskmise

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest STERIS PLC

STERIS plc provides infection prevention products and services worldwide. It operates through three segments: Healthcare, Applied Sterilization Technologies (AST), and Life Sciences. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in surgical tables, lights, and connectivity solutions, as well as equipment management services. It also provides capital equipment installation, maintenance, upgradation, repair, and troubleshooting services; preventive maintenance programs and repair services; instrument, devices, and endoscope repair and maintenance services; and custom process improvement consulting and outsourced instrument sterile processing services. The AST segment provides contract sterilization and testing services for medical device and pharmaceutical manufacturers through a network of contract sterilization and laboratory facilities, as well as integrated sterilization equipment and control systems to medical device manufacturers and research institutions. The Life Sciences segment designs, manufactures, and sells consumable products, such as pharmaceutical detergents, cleanroom disinfectants and sterilants, pharmaceutical grade and research sterilizers and washers, sterility assurance and maintenance products, vaporized hydrogen peroxide room decontamination systems and sterilizers, and high purity water and pure steam generators. This segment also offers equipment installation, maintenance, upgradation, repair, and troubleshooting services; and preventive maintenance programs and repair services. It serves its products and services to hospitals, other healthcare providers, and pharmaceutical manufacturers. The company was founded in 1985 and is headquartered in Mentor, Ohio.